Related Experiment Video
Updated: May 29, 2025

Visualization of DNA Repair Proteins Interaction by Immunofluorescence
Published on: June 26, 2020
Phosphorylation of SIRT7 by ATM causes DNA mismatch repair downregulation and adaptive mutability during chemotherapy
Lianhui Sun1, Guangjian Fan1, Zhuqing Zhang1
1Biomedical Translational Research Institute, School of Life Sciences and Medicine, Shandong University of Technology, Zibo 255049, China.
Abstract:
Drug resistance significantly limits the efficacy of chemotherapy. The DNA mismatch repair (MMR) system maintains genomic stability by correcting DNA errors. During DNA-damaging treatments, cancer cells transiently increase their adaptive mutability, also known as microsatellite instability (MSI), to evade therapeutic pressure through MMR downregulation, conferring drug resistance. However, an understanding of the underlying mechanisms of MMR protein downregulation under DNA-damaging drugs remains limited. Our study reveals a negative correlation between SIRT7 protein levels and MMR core protein MSH2 levels in cervical and lung cancer tissues. SIRT7 destabilizes MSH2, promoting MSI and mutagenesis. Molecularly, DNA damage triggers ATM kinase-dependent phosphorylation and subcellular redistribution of SIRT7. Phosphorylated SIRT7 interacts with and deacetylates MSH2, impairing MMR, and inducing MSI and drug resistance. Our findings suggest that SIRT7 drives MMR downregulation under therapeutic stress and that ATM-dependent phosphorylation of SIRT7 may serve as a predictive biomarker for chemotherapeutic efficacy and a target for cancer treatment.
Insights
Cancer cells evade chemotherapy by downregulating DNA mismatch repair (MMR) via SIRT7 protein, which destabilizes MSH2. This promotes microsatellite instability (MSI) and drug resistance, suggesting SIRT7 as a therapeutic target.
Area of Science:
- Molecular Oncology
- Genomic Stability
- Cancer Drug Resistance
Background:
- Drug resistance limits chemotherapy efficacy.
- DNA mismatch repair (MMR) maintains genomic stability.
- Cancer cells develop drug resistance by downregulating MMR, increasing microsatellite instability (MSI).
Purpose of the Study:
- Investigate mechanisms of MMR protein downregulation during DNA-damaging treatments.
- Clarify the role of SIRT7 in MMR deficiency and drug resistance.
Main Methods:
- Analysis of SIRT7 and MSH2 protein levels in cervical and lung cancer tissues.
- Investigating the molecular interactions between SIRT7, MSH2, and ATM kinase.
- Assessing the impact of SIRT7 on MMR, MSI, and drug resistance.
Main Results:
- A negative correlation was observed between SIRT7 and MSH2 protein levels.
- SIRT7 destabilizes MSH2, leading to MSI and mutagenesis.
- DNA damage induces ATM-dependent phosphorylation and redistribution of SIRT7, impairing MMR and conferring drug resistance.
Conclusions:
- SIRT7 drives MMR downregulation under therapeutic stress.
- ATM-dependent SIRT7 phosphorylation is a potential predictive biomarker for chemotherapeutic efficacy.
- SIRT7 represents a potential therapeutic target for overcoming cancer drug resistance.
More Related Videos
Related Concept Videos
DNA Damage can Stall the Cell Cycle
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Abnormal Proliferation
Overview of DNA Repair
Chemically...
Restarting Stalled Replication Forks

